...
首页> 外文期刊>Acta biomaterialia >Injectable biodegradable hybrid hydrogels based on thiolated collagen and oligo(acryloyl carbonate)-poly(ethylene glycol)-oligo(acryloyl carbonate) copolymer for functional cardiac regeneration
【24h】

Injectable biodegradable hybrid hydrogels based on thiolated collagen and oligo(acryloyl carbonate)-poly(ethylene glycol)-oligo(acryloyl carbonate) copolymer for functional cardiac regeneration

机译:基于硫醇化胶原蛋白和低聚(丙烯酰碳酸酯)-聚(乙二醇)-低聚(丙烯酰碳酸酯)共聚物的可注射生物降解混合水凝胶,用于功能性心脏再生

获取原文
获取原文并翻译 | 示例
           

摘要

Injectable biodegradable hybrid hydrogels were designed and developed based on thiolated collagen (Col-SH) and multiple acrylate containing oligo(acryloyl carbonate)-b-poly(ethylene glycol)-b-oligo(acryloyl carbonate) (OAC-PEG-OAC) copolymers for functional cardiac regeneration. Hydrogels were readily formed under physiological conditions (37 degrees C and pH 7.4) from Col-SH and OAC-PEG-OAC via a Michael-type addition reaction, with gelation times ranging from 0.4 to 8.1 min and storage moduli from 11.4 to 55.6 kPa, depending on the polymer concentrations, solution pH and degrees of substitution of Col-SH. The collagen component in the hybrid hydrogels retained its enzymatic degradability against collagenase, and the degradation time of the hydrogels increased with increasing polymer concentration. In vitro studies showed that bone marrow mesenchymal stem cells (BMSCs) exhibited rapid cell spreading and extensive cellular network formation on these hybrid hydrogels. In a rat infarction model, the infarcted left ventricle was injected with PBS, hybrid hydrogels, BMSCs or BMSC-encapsulating hybrid hydrogels. Echocardiography demonstrated that the hybrid hydrogels and BMSC-encapsulating hydrogels could increase the ejection fraction at 28 days compared to the PBS control group, resulting in improved cardiac function. Histology revealed that the injected hybrid hydrogels significantly reduced the infarct size and increased the wall thickness, and these were further improved with the BMSC-encapsulating hybrid hydrogel treatment, probably related to the enhanced engraftment and persistence of the BMSCs when delivered within the hybrid hydrogel. Thus, these injectable hybrid hydrogels combining intrinsic bioactivity of collagen, controlled mechanical properties and enhanced stability provide a versatile platform for functional cardiac regeneration. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:基于硫醇化胶原蛋白(Col-SH)和包含低聚(丙烯酸丙烯酯)-b-聚(乙二醇)-b-低聚(丙烯酸丙烯酯)(OAC-PEG-OAC)共聚物的多种丙烯酸酯设计并开发了可注射生物降解的混合水凝胶用于功能性心脏再生。在生理条件(37摄氏度和pH 7.4)下,通过Michael型加成反应,由Col-SH和OAC-PEG-OAC容易形成水凝胶,胶凝时间为0.4至8.1分钟,存储模量为11.4至55.6 kPa取决于聚合物的浓度,溶液的pH值和Col-SH的取代度。杂化水凝胶中的胶原成分保留了其对胶原酶的酶促降解能力,并且水凝胶的降解时间随着聚合物浓度的增加而增加。体外研究表明,骨髓间充质干细胞(BMSC)在这些杂化水凝胶上表现出快速的细胞扩散和广泛的细胞网络形成。在大鼠梗塞模型中,向梗塞的左心室注射PBS,混合水凝胶,BMSC或包封BMSC的混合水凝胶。超声心动图显示,与PBS对照组相比,杂合水凝胶和BMSC包裹的水凝胶可在28天时增加射血分数,从而改善心脏功能。组织学表明,注射的杂化水凝胶显着减小了梗塞面积并增加了壁厚,并且通过包封BMSC的杂化水凝胶处理进一步改善了梗塞面积,这可能与在杂化水凝胶中递送时BMSC的植入和持久性增强有关。因此,这些可注射的混合水凝胶结合了胶原蛋白的固有生物活性,受控的机械性能和增强的稳定性,为功能性心脏再生提供了多功能平台。 (C)2014 Acts Materialia Inc.,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号